In California, Amyris announced that it has executed an agreement for a significant project consortium in Europe with the Universidade Católica Portuguesa (UCP) Porto Campus and AICEP Portugal Global (AICEP). UCP is a university system, including the leading biotech school in Portugal, and operates 15 research centers. AICEP is an independent public entity of the Government of Portugal, focused in encouraging the best foreign companies to invest in Portugal.
The announcement is a follow up to the announcement Amyris made on January 17, 2018 regarding grants in both Europe and with the National Institute of Health, with the grant in Europe tied to the project consortium announced. The project goals entail collaboration in advancing the use of Amyris’s leading technology platform and capabilities to, among other things:
Explore means of using waste from fermentation to develop new products and applications from co-products. This valorization of co-products is expected to significantly reduce production cost and create additional sustainability in the production process.
Advance Amyris’s artificial intelligence (AI) and Informatics platform. This includes providing a cloud-based interface whereby universities and companies could utilize aspects of the company’s advanced platform to design genes for potential molecule development. Amyris would be positioned to take development and testing of marketable target molecules to the next level and commercial scale.